Statistics

Total Visits

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients12

Select a period of time:

Number of views in the range

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients10

Views

Views
May 20241
June 20243
July 20242
August 20241
September 20240
October 20243
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
United Kingdom2
 

Top cities views

Views
Fort Worth2
Chicago1